Korean journal of clinical oncology · 2025
Patients participation in multidisciplinary management in gastric cancer: regulation comparison and expert survey among major countries.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Park Kyoyoung, Lee Hyuk-Joon, Kong Seong-Ho, Park Do Joong, Chung Hyunsoo, Cho Soo-Jeong, Im Seock-Ah, Kwak Yoonjin, Lee Hye Seung, Chie Eui Kyu, So Jimmy Bok Yan, Xu Zekuan, Boku Narikazu, Ji Jiafu, Kitagawa Yuko, Rosenthal Raul J, Sano Takeshi, Yang Han-Kwang
Аннотация
PURPOSE: In Korea, the Health Insurance Review and Assessment Service (HIRA) mandates patient participation in outpatient multidisciplinary team (MDT) meetings as part of national cancer quality assessment. However, the necessity of involving patients and families in MDT discussions remains debatable. This study explored international expert perspectives on patient participation in gastric cancer MDTs.
METHODS: A cross-national expert survey was conducted in September 2021 among 15 gastric cancer specialists from Korea, China, Japan, Singapore, and the United States. The survey assessed the frequency of patient and family member attendance, perceived pros and cons, and preferences regarding mandatory versus selective involvement. Additionally, MDT structures and policies were reviewed by countries.
RESULTS: Most respondents reported that patients and families rarely or never attend MDT meetings: nine stated that patients are never included, three reported "usually not," and three indicated "sometimes." None consistently included patients. The most cited benefits were sharing opinions with patients and families simultaneously, followed by improved explanation of treatment and legal protection. Major concerns included hindered discussion, inefficiency, and logistical challenges. Only four respondents supported routine participation, while 11 favored case-dependent involvement.
CONCLUSION: International experts do not widely support mandatory patient participation in MDT meetings. A flexible approach that allows MDTs to operate with or without patient involvement may better reflect actual clinical practice.
METHODS: A cross-national expert survey was conducted in September 2021 among 15 gastric cancer specialists from Korea, China, Japan, Singapore, and the United States. The survey assessed the frequency of patient and family member attendance, perceived pros and cons, and preferences regarding mandatory versus selective involvement. Additionally, MDT structures and policies were reviewed by countries.
RESULTS: Most respondents reported that patients and families rarely or never attend MDT meetings: nine stated that patients are never included, three reported "usually not," and three indicated "sometimes." None consistently included patients. The most cited benefits were sharing opinions with patients and families simultaneously, followed by improved explanation of treatment and legal protection. Major concerns included hindered discussion, inefficiency, and logistical challenges. Only four respondents supported routine participation, while 11 favored case-dependent involvement.
CONCLUSION: International experts do not widely support mandatory patient participation in MDT meetings. A flexible approach that allows MDTs to operate with or without patient involvement may better reflect actual clinical practice.